Zhe-Ling Chen (Z Chen, Zheling Chen)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Chemotherapy Induced

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Cancer control : journal of the Moffitt Cancer Center

Surgical endoscopy

The Journal of international medical research

This page only lists publications with an associated author ORCID identifier.

Publications

Hong-Rui Lu, Peng-Fei Zhu, Ya-Ya Deng, Zhe-Ling Chen, Liu Yang
Predictive value of NLR and PLR for immune-related adverse events: a systematic review and meta-analysis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Ke Chen, Xiao Wang, Liu Yang, Zhe-Ling Chen
The Anti-PD-1/PD-L1 Immunotherapy for Gastric Esophageal Cancer: A Systematic Review and Meta-Analysis and Literature Review. Cancer control : journal of the Moffitt Cancer Center 28 (2021)
Zhe-Ling Chen, Xiao Wang, Xiao Li, Yucheng Zhou, Ke Chen
Deep exploration of PARP inhibitors in breast cancer: monotherapy and combination therapy. The Journal of international medical research 49 (2) (2021)
Ke Chen, Yucheng Zhou, Weiwei Jin, Qicong Zhu, Chao Lu, Nan Niu, Yuanyu Wang, Yiping Mou, Zhe-Ling Chen
Laparoscopic pancreaticoduodenectomy versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic outcomes and long-term survival. Surgical endoscopy 34 (5) (2019)
K Chen, J Quan, J Yang, Zhe-Ling Chen
The potential markers of endocrine resistance among HR+ /HER2+ breast cancer patients. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (4) (2019)